Cargando…
Ultrasound-assisted intravesical botulinum toxin A delivery attenuates acetic acid—induced bladder hyperactivity in rats
Background: Intradetrusor injection of botulinum toxin A (BTX-A) is an effective treatment for overactive bladder (OAB). However, the occurrence of adverse events associated with BTX-A injection therapy hinders its acceptance among patients and its clinical promotion. Intravesical instillation of BT...
Autores principales: | Liu, Qinggang, Gao, Yi, Cong, Huiling, Liao, Limin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406439/ https://www.ncbi.nlm.nih.gov/pubmed/37554988 http://dx.doi.org/10.3389/fphar.2023.1214145 |
Ejemplares similares
-
Nano-BTA: A New Strategy for Intravesical Delivery of Botulinum Toxin A
por: Liu, Qinggang, et al.
Publicado: (2022) -
Pharmacotherapy in Pediatric Neurogenic Bladder Intravesical Botulinum Toxin Type A
por: Sager, Cristian, et al.
Publicado: (2012) -
Hengli(®) Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
por: Liao, Limin, et al.
Publicado: (2022) -
Conservative management of hostile bladders with intravesical botulinum toxin for successful renal transplantation
por: Niu, Sida, et al.
Publicado: (2018) -
Novel Applications of Non-Invasive Intravesical Botulinum Toxin a Delivery in the Treatment of Functional Bladder Disorders
por: Jhang, Jia-Fong, et al.
Publicado: (2021)